Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-11 · accession 0001171843-22-003615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-12 | 2022-05-11 | ANIK | Colleran David | EVP, GC, Corp Sec | P - Purchase | $21.37 | +1,500 | 9,867 | +18% | +$32.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-11 | P | A | 1,500 | $21.37 | 9,867 | D | — | — |